Eversept Partners, LP
SEC Form 13F institutional filer · CIK 0001697013
13F-HR · 10 reported holdings · 2026-03-31
Reported long-US-equity value
$0.18B
Top-10 concentration
100.0%
Eversept Partners, LP — $184M AUM allocation strategy
Eversept Partners, LP files SEC Form 13F and reports $184M of long US equity value across 10 reported holdings for 2026-03-31.
Its largest sector bet is Health Care 62.9%, followed by Real Estate 37.1%.
The top 10 holdings account for 100% of reported value — a conviction-weighted book concentrated in its best ideas. The sector and industry splits below are of the same reported value. Track quarter-over-quarter adds, trims, new positions and exits below — sourced from SEC 13F filings, public domain.
Eversept Partners, LP — latest SEC 13F insights
Reported long-US-equity value (13F AUM)
$184M
total across 10 reported holdings · 2026-03-31 · excludes shorts, cash, non-US
Top-10 concentration
100% of value
higher = narrower conviction; lower = spread / hedging
Biggest trims (shares)
−$TECH −252K sh · −$15.6M−$CNC −212K sh · −$9.68M−$MRNA −108K sh · +$215K
Exited to nil (held last quarter, gone now)
$DHR ($42.6M last qtr)$UNH ($20.1M last qtr)$BIIB ($13.7M last qtr)$BMY ($12.7M last qtr)$ELV ($10.6M last qtr)
Sector allocation (share of reported value)
each slice is a share of the reported long-US-equity value — smaller sectors and the rest of the book roll into “Other holdings”
Qtr shift = share-point change vs the prior quarter's filing — first period tracked for this filer; the column fills in with the next quarterly refresh.
Industry allocation (share of reported value)
- Health Care REITs37.1%—
- Health Care Equipment23.2%—
- Health Care Facilities20.3%—
- Pharmaceuticals9.5%—
- Biotechnology4.4%—
- Life Sciences Tools & Services3.6%—
- Managed Health Care2.0%—
the finer GICS cut of the same book — same denominator — smaller industries roll into “Other holdings”
Qtr shift = share-point change vs the prior quarter's filing — first period tracked for this filer; the column fills in with the next quarterly refresh.
Top S&P 500 holdings
10 of 10 rows · sorted by Value ↓
| Ticker | Holding | Shares | Value | Δ QoQ | Weight |
|---|---|---|---|---|---|
| $HCA | HCA Healthcare Inc | 79.2K | $37.5M | -16.6K | 20.3% |
| $WELL | Welltower Inc | 181K | $35.8M | — | 19.4% |
| $DOC | Healthpeak Properties Inc | 1.98M | $32.5M | — | 17.7% |
| $PODD | Insulet Corporation | 144K | $30.1M | +68.8K | 16.3% |
| $LLY | Eli Lilly and Company | 19K | $17.5M | +8.38K | 9.5% |
| $MRNA | Moderna Inc | 160K | $8.11M | -108K | 4.4% |
| $RVTY | Revvity Inc | 84.9K | $7.43M | -77.9K | 4.0% |
| $TECH | Bio-Techne Corp | 126K | $6.58M | -252K | 3.6% |
| $ISRG | Intuitive Surgical Inc | 11.1K | $5.13M | -6.94K | 2.8% |
| $CNC | Centene Corporation | 112K | $3.66M | -212K | 2.0% |
SEC Form 13F data sets · public domain · 45-day filing lag · >$100M AUM managers · as reported
← All 13F filers·← QuantOrb.pro
How to read Δ QoQ — the five insight categories, and the caveats
The categories. Analysts, quants and retail traders look past total portfolio value to isolate actionable signals. Five categories matter.
Conviction & concentration shifts
New positions vs complete exits — a brand-new stock signals high conviction; a full liquidation suggests a broken thesis or tax-loss harvesting. Aggressive sizing — look at share count, not dollars: a 20% share increase during a drawdown is strong dip-buying. Concentration — a narrowing top-5/10 means conviction; spreading capital across more names means hedging.
Sector & macro allocation rotations
Aggregating Δ QoQ moves across sectors shows where smart money is leaning in or sneaking out — rotating out of growth into defensives or energy, for example. The fund's total long equity exposure quarter-over-quarter is a proxy for overall institutional risk appetite.
Crowding & smart-money consensus
When several managers initiate or expand the same stock in the same quarter, that is institutional consensus. Contrarian reads: top pickers buying hard into a beaten-down name the market is selling.
Derivative & option overlays
Reported call/put changes indicate whether managers are adding downside hedges or leveraging upside exposure. Note: a long increase may be half of a market-neutral pair trade.
Who reads this
| Retail "cloners" | High-conviction ideas to replicate ~45 days after quarter-end. |
| Corporate IR | Which funds bought or dumped the stock, before the next call. |
| Quant / algo traders | Cross-sectional factor inputs: flow, momentum, ownership. |
Four caveats before you trade on it
- 45-day lag — holdings are quarter-end; positions may already be closed.
- Long-only — 13Fs miss shorts, pair trades and cash.
- No non-US / fixed income — the picture is US equities plus options.
- Corporate actions — splits and spinoffs distort raw share deltas.
Newsletter signup
Free subscription. Daily trading day morning dispatch. No spam.